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Abstract
Nanotechnology is quickly becoming incorporated into everyday products
and uses.

Silver nanoparticles, specifically, are being used in commercial

products, to include aerosols. The purpose of this research was to determine
whether silver nanoparticles are toxic to human lung epithelial cells. Different
types (coated vs. uncoated), concentrations (10, 50, 100, and 200 µg/mL) and
sizes (coated 5 and 80nm, uncoated 10 and 80nm) of silver nanoparticles were
used during this study. Toxicity measurements were completed through in vitro
techniques.

Another study was also completed on toxicity mechanisms by

measuring the reactive oxygen species (ROS) generated. Results showed that
silver

nanoparticles

induce

mitochondrial

toxicity

through

a

size

and

concentration dependent manner. Increasing the concentration yielded increased
toxicity and the smaller the size induced increased toxicity to the mitochondria.
Results also showed that the uncoated nanoparticles were also more toxic to the
cells than the coated nanoparticles. The small nanoparticles (coated 5, uncoated
10nm) induced more formation of the ROS than the larger nanoparticles (80nm).

iv

Acknowledgments

I would like to express my sincere appreciation to my research advisors, Drs.
Kyung Yu and Saber Hussain from the Air Force Research Laboratories (RHPB)
for all their advice and assistance throughout the research time that I spent in the
lab. Their insight and help has been invaluable to both this thesis and for my
future. I would, also, like to thank my faculty advisor, Lt. Col. David A. Smith, for
his guidance and support throughout the course of this thesis effort. Finally; I
thank my fiancé, who has stood beside me throughout it all.

Christina R. Kearns
CPT, USA

This Note is not to be included with the Acknowledgments – it is for information only: It is prohibited to include
any personal information in the following categories about U.S. citizens, DOD Employees and military personnel:
social security account numbers; home addresses; dates of birth; telephone numbers other than duty officers
which are appropriately made available to the general public; names, locations and any other identifying
information

about

family

members

of

DOD

v

employees

and

military

personnel.

Table of Contents

Page
Abstract................................................................................................................ iv
Acknowledgments ................................................................................................. v
Table of Contents................................................................................................. vi
List of Figures ..................................................................................................... viii
I. Introduction ........................................................................................................ 1
1.1. Chapter Overview.................................................................................... 1
1.2. Problem Statement.................................................................................. 2
1.3. Research Questions ................................................................................ 3
1.4. Significance of Results ............................................................................ 3
1.5. Research Focus ...................................................................................... 3
1.6. Methodology ............................................................................................ 4
1.7. Assumptions ............................................................................................ 6
1.8. Implications ............................................................................................. 7
1.9. Document Overview ................................................................................ 7
II. Literature Review .............................................................................................. 8
2.1. Background ............................................................................................. 8
2.2. Nanoparticles ........................................................................................ 11
2.3. Health and Safety .................................................................................. 17
2.4. Surface Characteristics ......................................................................... 20
2.5. Nanotoxicity and Bioterrorism ............................................................... 21
2.6. Cellular Assays...................................................................................... 24
2.7. Current Research and Applications ....................................................... 28
2.8. Summary ............................................................................................... 29
III. Methodology .................................................................................................. 31
3.1. Introduction ........................................................................................... 31
3.2. Assumptions .......................................................................................... 32
3.3. Cell Lines .............................................................................................. 32
3.4. Cell Culture and Splitting ....................................................................... 32
3.5. Absorbance and Fluorescence Readings .............................................. 33
3.6. Nanoparticles ........................................................................................ 33
3.7. MTT Assay ............................................................................................ 35
3.8. MTS Assay ............................................................................................ 36
3.9. LDH Assay ............................................................................................ 37
3.10. Reactive Oxygen Species (ROS) Assay ............................................. 37
3.11. Dynamic Light Scattering and Transmission Electron Microscopy ...... 38
3.12. CytoViva™ ........................................................................................... 39

vi

3.13. Statistical Analysis............................................................................... 40
IV. Data Description and Analysis ....................................................................... 41
4.1. Introduction ........................................................................................... 41
4.2. Results .................................................................................................. 41
4.3. Dynamic Light Scattering and Transmission Electron Microscopy ........ 60
4.4. CytoViva™ ............................................................................................. 62
4.5. Summary ............................................................................................... 64
V. Conclusions and Future Research Considerations......................................... 66
5.1. Overview ............................................................................................... 66
5.2. Investigative Questions Answered ........................................................ 67
5.3. Recommendations for Future Research ................................................ 68
Appendix A: Cell Culturing and Splitting ............................................................ 70
Appendix B: Cell Growth Curve Procedure ........................................................ 71
Appendix C: MTT Assay .................................................................................... 73
Appendix D: MTS Assay .................................................................................... 75
Appendix E: Lactate Dehydrogenase (LDH) Assay ........................................... 78
Appendix F: Reactive Oxygen Species (ROS) Assay ........................................ 80
Bibliography ........................................................................................................ 82

vii

List of Figures
Figure

Page

1: Scale of Nanoparticles Compared to Other Objects (from
http://www.nano.gov/html/facts/nanoscale.html) ........................................... 12
2: Cell Mitochondria ........................................................................................... 15
3: Overview of Cytotoxicity and Antibacterial Properties of Silver
Salts versus Nanosilver Use in Bone Cement (modified from Alt,
et al., 2004) ................................................................................................... 19
4: Schematics of the molecular events by which nanoparticles (NP)
exert their toxic effects at the cellular level (modified from Buzea
& Blandino, 2007) ......................................................................................... 23
5: Stepwise reduction of oxygen (modified from Boelsterli, 2007) ..................... 26
6: Oxidative DNA Damage Can Lead to Apoptosis ............................................ 27
7: Nanoparticle Solutions Prepared for Dosing Plates ....................................... 35
8: Seven Day Growth Curve with Trend Line ..................................................... 42
9: MTS Assay - 24 Hour Exposure..................................................................... 44
10: MTS Assay - 48 Hour Exposure................................................................... 45
11: MTS Assay - 72 Hour Exposure................................................................... 46
12: Combined MTS Assay Results - 48 Hour Exposure – (*) indicate
statistically significant variation from the control ........................................... 48
Figure 13: LDH Assay - 24 Hour Exposure ........................................................ 50
Figure 14: LDH Assay - 48 Hour Exposure ........................................................ 51
Figure 15: LDH Assay - 72 Hour Exposure ........................................................ 52
Figure 16: Combined LDH Assay Results - 48 Hour Exposure .......................... 53
Figure 17: 96-Well Black Plate for ROS Assay after 1 Hour Incubation ............. 54

viii

Figure

Page

18: Reactive Oxygen Species Results for Uncoated 5 nm - (*) indicate
statistically significant variation from the control ........................................... 56
19: Reactive Oxygen Species Results for Coated 10 nm - (*) indicate
statistically significant variation from the control ........................................... 57
20: Reactive Oxygen Species Results Uncoated 80 nm - (*) indicate
statistically significant variation from the control ........................................... 58
21: Reactive Oxygen Species Assay Results for Coated 80 nm ........................ 59
22: Transmission Electron Microscope Images of Ag Nanoparticles.
Images were taken at 100 kV and 100 kx magnification on a
formvar-carbon coated Cu grid. (A) Ag 5 nm uncoated. (B) Ag 80 nm
uncoated. (C) Ag 10 nm coated. (D) Ag 80 nm coated .............................. 61
23: CytoViva™ Picture at 60X (60-times) magnification of the A549 Cells
(10 µg/mL solution) ....................................................................................... 63
24: CytoViva™ Pictures at 60X (60 times) magnification of the Silver
Nanoparticles and the A549 Cell Line (10 µg/mL solution) – (A)
Coated 10 nm, (B) Coated 80 nm, (C) Uncoated 5 nm, (D) Uncoated
80 nm ............................................................................................................ 64

ix

List of Tables
Table

Page

1: Experimental Nanoparticles ............................................................................. 4
2: Experimental Nanoparticle Sizes and Concentrations ................................... 34
3: Characterization Data for Ag Nanoparticles ................................................... 62
4: Example of 24-well MTT Plate ....................................................................... 73
5: Example of a 96-Well Plate ............................................................................ 76
6: Dosing solution calculations (1mL Solution) .................................................. 77

x

IN VITRO TOXICITY OF SILVER NANOPARTICLES IN HUMAN LUNG
EPITHELIAL CELLS

I. Introduction
1.1. Chapter Overview
Nanoparticle research is an ever increasing scientific research interest,
especially over the last couple decades. Nanoparticles and nanomaterials are
quickly becoming part of everyday lives. Current applications are seen in many
useful products: water filters, hair appliances, socks, wound dressings, dental
bonding agents, etc. (National Nanotechnology Initiative, 2008). The Department
of Defense is involved in developing the nanotechnology field. For instance, the
FY08 budget allocated for the national Nanotechnology Initiative was
approximately $1.5 billion, with the Department of Defense (DoD) receiving
almost $487 million. The projected budget for FY09 is over $1.5 billion with a
projected DoD allocation of $431 million (National Nanotechnology Initiative,
2008).

Applications for Department of Defense can include the use of

nanoparticles in chemical and biological defense and detection, as well as
personal protective equipment. Further research in this area is needed to
determine the extent nanoparticles will play in biological weapons of mass
destruction (WMD) defense.

However, the toxicity associated with these

nanoparticles has not been evaluated thoroughly. This study links the potential
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bioterrorism aspects and the toxicity of nanoparticles together while looking at
the effects of the nanoparticle exposure on lung cells.
Nanoparticles are materials that measure between 1 and 100
nanometers (nm) in one dimension.

Nanoscience involves investigation into

learning new properties of nanosize materials (National Nanotechnology
Initiative, 2008). At the nanoscale, objects behave quite differently from those at
larger scales.

Some nanoparticles may be toxic compared the bulk parent

material. For instance, gold at the bulk scale is an excellent conductor of heat
and electricity, but not of light. Gold nanoparticles, on the other hand, have the
ability to absorb light; therefore creating heat that can kill unneeded cells in the
human body (National Nanotechnology Initiative, 2008).

This is due to the

decrease in size and volume resulting increased surface area to volume ratio.
The increased nanoparticle surface area can more readily interact with cells,
producing harmful effects.
1.2. Problem Statement
Nanoparticle research is a new area in the scientific community and is
growing significantly. Toxicity levels (observed effects or lethal concentration)
have not been determined for most nanoparticles. As this research field grows,
the applications of nanoparticles are increasing. Nanoparticle toxicity levels must
be determined to keep the population safe.
The present study is intended to determine cell viability in the presence of
silver nanoparticles.

The cell viability will be assessed by determining

2

mitochondrial function and membrane leakage in human lung cells. Furthermore,
it is intended to determine the generation of reactive oxygen species (ROS)
generated by the silver nanoparticles in the A549 (American Type Culture
Collection, ATCC) lung epithelial cells.
1.3. Research Questions
1. Are silver nanoparticles toxic to the A549 (ATCC) lung epithelial cells?
2. Does the exterior coating of the nanoparticles affect toxicity?
3. Does the size difference of the nanoparticles affect toxicity?
1.4. Significance of Results
The use of nanoparticles for defense and detection from weapons of mass
destruction is a credible and working option for the DoD. Understanding the
results of this study and how silver nanoparticles can affect human lung cells at
certain levels may be able to show us how to defend against or detect weapons
of mass destruction, as well as how aerosols in industrial settings may affect
human lungs. Depending on the toxicity levels, nanoparticles could potentially be
toxic when used for chemical or biological weapons defense and detection.
1.5. Research Focus
1. To determine the toxicity of silver nanoparticles based on size and coating
in lung cell models.
2. To investigate the mechanisms of toxicity.
3. Predict toxicity from in vitro to in vivo by using kinetic modeling approach.

3

1.6. Methodology
1.6.1. Nanoparticles
Table 1 shows the different nanoparticles used during this study.

The

nanoparticles were received from Clarkson University. The nanoparticles are
either: coated or uncoated. The coated nanoparticles have a polysaccharide
coating. The specifics of the polysaccharide coating are not known. These two
categories are further broken down to small (<10 nm) and large (80 nm)
nanoparticles. During this study, toxicity differences were observed based on the
nanoparticle concentration, coating of the nanoparticle, and the size of the
nanoparticle (small vs. large).
Table 1. Experimental Nanoparticles

Silver Nanoparticles
Coated
(polysaccharide coating)
Uncoated

Small

Large

10 nm

80 nm

5 nm

80 nm

1.6.2. Methods
Several methods were employed throughout this research.

First and

foremost was cell harvesting. During cell harvesting, A549 (ATCC) human lung
epithelial cells needed during the experimental process were cultured as
described in Appendix A and in accordance with the ATCC guidelines.
After completing cell harvesting, a growth curve of the cells was
determined. A549 cells were grown over seven days to determine the normal
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growth rate without nanoparticle interference or interaction.

Along with the

growth curve, the MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5 diphenyltetrazolium
bromide) assay was used to determine the cell viability daily. The assay was an
indicator that the cells were still alive and growing throughout the growth curve
period. This is a colorimetric test measuring activity of enzymes that reduce MTT
for formazan. The MTT assay indicates cell viability through a yellow to purple
color change, measured by a light absorbance reading at 490 nm.
After the growth rate was determined, the cells were dosed with different
nanoparticle concentrations for each different nanoparticle used. The fist assay
used was the MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethophenyl)-2-(4sulfonyl)-2H-tetrazolium, inner salt) assay.

This assay is also a colorimetric

method used to identify the cytotoxic potential of the nanoparticles and determine
cell viability via a light absorbance reading at 490 nm.
The next assay used was the LDH (lactate dehydrogenase) assay. This
assay was used to determine the cell cytotoxicity by measuring the LDH leakage
across the plasma membrane.

This assay also required a light absorbance

reading at 490 nm.
The last assay used was the reactive oxygen species (ROS) assay. This
assay measured the formation of ROS created by silver nanoparticle exposure.
This assay used a fluorescence reading at an excitation wavelength of 485 ±
20nm and an emission wavelength of 528 ± 20nm.
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Transmission Electron Microscopy (TEM) was completed on the different
nanoparticles to obtain the mean sizes (and standard deviation) and morphology
of each different type.
Dynamic Light Scattering (DLS) was used for characterization of the
nanoparticle sizes and agglomeration of nanoparticles in solution.
CytoViva™ was completed to observe the nanoparticle interaction with the
cell line after 24 hours of exposure.
1.7. Assumptions
1. There is a uniform distribution of silver nanoparticles dosing of the lung
epithelial cells, allowing for equal exposure of the cells to the nanoparticles.
2. Cells dosed at the same concentration of silver nanoparticles each receive
the same level of exposure throughout each assay.
3. In vitro studies can give insight to in vivo studies, not give an exact
determination of toxicity.
The nanoparticles solutions were sonicated prior to making the dosing
solutions for approximately 10-12 seconds. Also, prior to dosing the cell plates,
all solutions are stirred by a vortex stirrer to ensure even distribution in the
solution.
In vitro studies can only show correlation with in vivo studies, but cannot
replace an experimental study that is done using in vivo techniques. They can
show some correlation to each other. Both types of studies are compared during
in the literature review (Chapter 2).
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1.8. Implications
This study provides toxic or biological properties of silver nanoparticles
based on their physicochemical properties. The results will give insight to the
material scientists to synthesize biocompatible and safe nanomaterials by
modifying surface properties.
1.9. Document Overview
This paper studies the toxicity of silver nanoparticles in human lung
epithelial cells. It includes the use of several different assays to determine the
toxicological effects on the cell line:

mitochondrial activity assay, membrane

leakage assay, and reactive oxygen species assay. Each type of assay was
completed at least three times for statistical significance.

The assays are

described in Chapter 3. The results of the assays and characterizations are
found in Chapter 4. Conclusions drawn from this study are found in Chapter 5.
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II. Literature Review
2.1. Background
This chapter addresses the relevance of nanoparticles to bioterrorism
detection and defense, to include historical bioterrorism.

The chapter also

discusses nanoparticle characteristics and toxicity, followed with more specifics
on silver nanoparticles used in this research.

It also addresses several

applications that may be associated with nanoparticles, to include possible use
as aerosols. Each assay used during this experiment is also discussed.
2.1.1 Bioterrorism
Biological weapons are easier to develop, more lethal, inexpensive to
produce, easier to deliver and the risk of detection is low as compared to
chemical and nuclear weapons (Radosavljevic V. B., 2007). These properties
create the appeal of bioweapons to terrorists. There are already many historical
instances of the use of biological weapons, to include: 1) 14th Century Tartar
besiegers were said to have catapulted plague infected corpses into the city of
Kaffa, 2) smallpox contaminated blankets were given to Pro-French Indians by
Lord Jeffery Amhurst, 3) Salmonella typhimurium poisoning of salad bars by the
Rajneeshe Cult in Oregon in 1984, 4) Texan laboratory technician poisoned 12 of
her fellow worker by inoculating Shigella dysenteriae into muffins and doughnuts
in the staff room (Spencer, 2007).
In 1972, the Biological and Toxin Weapons Commission (BTWC) placed
restrictions on the use of biological materials or chemicals that can be linked to
bioweapons or chemical weapons (Lee, Hadjipnanaysis, & Parker, 2005). The
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BTWC restricted the research of biological weapons to defensive research only;
no offensive research was to be done thereafter.
Although, the BTWC restricted offensive research of bioweapons, there is
belief that there are countries developing these types of weapons. In fact in
1998, the US Commission on National Security in the 21st Century determined
that biological agents were the most likely choice of weapons for rogue states
(Radosavljevic & Jakovljevic, 2007). Sadly, the U.S. has seen that this prediction
was accurate during the anthrax attacks of 2001. During the aftermath of the
anthrax attacks there has been a focus on weapons of mass destruction,
especially the biological and chemical weapons realms. The anthrax attacks
brought forth an old concern of weapons that have not been used in current
times, at least not in the United States.
It can be difficult to talk about a bioweapon without defining the term. A
bioweapon has been defined as the use of micro-organisms or the products of
living organisms (toxins) cause damage on a population (Spencer, 2007).

The

population affected can include people, animals and crops. The use of these
same micro-organisms as weapons can result in a major negative impact on a
nation’s physical, psychological or economic well-being (Spencer, 2007). This
was seen throughout the timeframe of the anthrax attacks. Nanoparticles could
fall within this bioweapon category. Although they are not living organisms, as
discussed later, they can be products of many natural processes.
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2.1.2. Nanoparticles and Bioterrorism Defense
While the discussion of bioterrorism continues, nanoparticles will have
their place in the development of combating future weapons. Nanoparticles are
abundant in nature. They are produced in many natural methods, to include:
photochemical reactions, volcanic eruptions, forest fires, and simple erosion,
plants, and animals (Buzea & Blandino, 2007).

In future research the

manipulation of these very small particles to defend against chemical or
biological weapons will be a focus.

Can they be effectively used to defend

against all routes of exposure (inhalation, ingestion or dermally absorbed)? Or
even used to predict exposure in the field?
The DoD has begun research to start answering these questions and has
a nanotechnology defense program. The long term objective for DoD in the
nanotechnology defense programs is:

‘to discover and exploit unique

phenomena at these dimensions to enable novel applications enhancing war
fighter and battle systems capabilities’ (Department of Defense, 2007). In 2002
the U.S. Army Research Office contracted with the Massachusetts Institute of
Technology (MIT) to found the Institute for Soldier Nanotechnologies (ISN)
(Massachusetts Institiute of Technology, 2008). This partnership was originally
contracted for five years, but has been extended for another five years. The
mission of the ISN is ‘to create better survivability materials to protect today’s
Soldiers’,

specifically

Technology, 2008).

using

nanomaterials

(Massachusetts

Institiute

of

The ISN addresses the questions from the previous

paragraph and has been working on the development of better chemical and

10

biological weapons defense equipment.

ISN has a Strategic Research Area

(SRA) dedicated to the Chemical/Biological Materials Science with a focus in
Detection and Protection (Massachusetts Institiute of Technology, 2008). This
shows that research in this field has already expanded to the DoD, making
further research in nanoparticles possible and important to the warfighter.
2.2. Nanoparticles
2.2.1. Overview
Nanoparticles, as defined earlier, are particles with at least one dimension
less than 100 nm. Nanoparticles have a large surface area that can interact with
the environment.

For instance, a size reduction from 10 microns to 10

nanometers will increase the contact surface area by 10 9 (Pal, Tak, & Song,
2007). This increases the contact surface area with which the particle can
interact with other matter: tissues, organs, and cells, for instance. In Figure 1,
the photo shows how a nanoparticle size compares to other objects. According
to Figure 1, a strand of hair is 100,000 times the width of a nanometer, knowing
this can put nanoparticle experiments into a relative perspective.
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Figure 1. Scale of Nanoparticles Compared to Other Objects (from
http://www.nano.gov/html/facts/nanoscale.html)
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As the industrial use of nanoparticles increases, so do the opportunities
for biological interaction of the nanoparticles to human cells. This interaction
may be dermal, through ingestion, or through inhalation. This study looks mainly
at the inhalation concern, but also considers the other two areas and they will be
discussed later in this chapter through the examples of previous studies.
Knowing the effects through these routes may give some insight into predicting
the effects on human lung cells.

Most studies of silver nanoparticle toxicity are

in vitro studies as opposed to in vivo studies.

Although this is the case, an in

vivo study will also be discussed later in the chapter.
2.2.2. Silver Nanoparticles
Silver has been used extensively for its antimicrobial properties in wound
dressings in order to fight infection as it is a safe, inorganic antibacterial agent.
Silver (including its ions and compounds) has been researched thoroughly for
toxicity, which in extremely small concentrations is nontoxic to human cells (Pal,
Tak, & Song, 2007). Silver (and its ions and compounds) is capable of killing
about 650 types of disease-causing microorganisms (Raffi, Hussain, Bhatti,
Akhter, Hameed, & Hasan, 2008).

Although nano-silver is highly toxic to

microorganisms, it shows a low toxicity toward mammalian cells. Raffi, et al.
(2008) calls nano-silver ‘oligodynamic’ due to its ability to exert a bactericidal
effect at minute concentrations.
A study by Raffi, et al. (2008) conducted tests on the antibacterial
properties of nanosilver. They observed the growth of Escherichia coli (E. coli)
under differing concentrations of silver nanoparticles. Silver nanoparticles in
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concentrations greater than 60 µg/mL were found to be effective bactericides
(Raffi, et al., 2008). Essentially, no growth of the E. coli was observed in trials
with a concentration greater than this. The number of remaining colony forming
units (CFUs) was inversely related to the concentration of silver nanoparticles.
In another study, scientists conducted an in vivo toxicology study of silver
nanoparticle effects on zebrafish embryos.

According to Berger (2008), the

researchers determined that silver nanoparticles have a high probability to induce
health and ecotoxicity issues in a concentration dependent mode. They found
that in concentrations greater that 50 µg/mL nanosilver treated embryos showed
visible signs of defects and altered physiological functions (slower heart rate,
axial curvatures and body part function loss) (Berger, 2008) (Asharani, Wu,
Gong, & Valiyaveettil, 2008).

It was not established, though, that silver

nanoparticles crossed the blood-brain barrier of the embryos.
In both studies, the E. coli and zebrafish embryo studies, the findings
showed similar silver nanoparticle concentrations that exhibited toxic effects.
These toxic level concentrations (60 µg/mL and 50 µg/mL, respectively) are
within a close proximity. The greater concentration was found in the in vitro
study and the lower in the in vivo study, showing some correlation with the in
vitro and in vivo toxicity studies.
In other studies, silver nanoparticle interactions with mitochondria have
been observed. Silver nanoparticles have been shown to be linked to decreasing
mitochondrial activity in cells (Chen & Schluesener, 2008). This is important
since mitochondria are often referred to as the powerhouse of the cell. They
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produce the energy required for the cell to function.

The cristae (inner

mitochondrial folds) and the matrix are involved in, and have different
responsibilities, during the energy producing functions of the mitochondria.
Figure 2 shows a picture of a mitochondrion and its parts. The cristae (the inner
folds of the mitochondria) and the inner membrane contain the molecules that
serve as the electron-transport chain during aerobic respiration (Fox, 2006). This
chain donates the electrons to the oxygen in the final oxidation-reduction reaction
in the electron-transport chain. The mitochondria are also involved in the
formation of the reactive oxygen species in cells. Reactive oxygen species will
be discussed in depth in section 2.6.4.

Outer Membrane
Inner Membrane

Cristae
Matrix

Figure 2. Cell Mitochondria

15

Silver nanoparticles are considered cytotoxic and cell exposure is
considered to be an early step in apoptosis. The mechanism(s) linked to silver
nanoparticle cytotoxicity is not completely understood. Raffi et al. (2008) suggest
that, in the study of E. coli, bacteria change membrane morphology producing a
significant increase in permeability affecting proper transport through the plasma
membrane. They observed that the silver nanoparticles penetrated into the
bacteria causing damage by interacting with phosphorus and sulfur containing
compounds, like DNA, and resulting in cell death (Raffi, Hussain, Bhatti, Akhter,
Hameed, & Hasan, 2008).
Chen and Schluesener (2008) agreed that silver nanoparticle interaction
with the thiol groups of the mitochondrial inner membrane occurs.

They

indicated that this leads to the depletion of the antioxidant defense mechanism
which, in turn, led to the formation of ROS. The ROS accumulation leads to an
inflammatory response.

The cells’ inflammatory response initiated the

destruction of mitochondria, which provoked the release of apoptogenic factors
that induce cell death (Chen & Schluesener, 2008).
Supporting these studies is a study by Hussain et al. (2005) who looked at
toxic response of silver nanoparticles (15 and 100 nm) in BRL 3A rat liver cells.
They found that silver nanoparticles induce a toxic response in this cell type.
Also, they determined that mitochondrial function diminished considerably in cells
exposed to silver nanoparticles at 5-50 µg/mL (Hussain, Hess, Gearhart, Geiss,
& Schlager, 2005).

It was also determined that there was significant LDH

leakage across the membrane in cells exposed to silver nanoparticles from 10-50
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µg/mL (Hussain, et al., 2005).

It was observed that along with the reduced

mitochondrial membrane potential, there was an increase in ROS levels
suggesting that the cytotoxicity of nanosilver was probably mediated through
oxidative stress (Hussain, et al., 2005). Also, the team observed that there was
an increase in ROS generation with an increase in nanoparticle concentration.
The study showed that after an exposure of 24 hours, the cells showed a
concentration dependent LDH leakage with significant cytotoxicity at 10-50
µg/mL (Hussain, et al., 2005). This team not only studied silver nanoparticles, but
also other nanomaterials (MoO3, Al, Fe3O4, and TiO2). They determined through
the use of MTT and LDH assays that the silver nanoparticles were more toxic
than the other nanomaterials noted above.
2.3. Health and Safety
Silver has a high degree of use in the medical field. Severe side effects
are a rare occurrence from silver poisoning, which is one reason for its common
medical usage.

When silver poisoning does occur, it only occurs in chronic

history of silver exposure (Chen & Schluesener, 2008).

As its use as

nanoparticles increases, the study of the silver nanoparticle interaction in the
human body becomes of greater importance as well as the different routes of
exposure. Also, as the use of nanoparticles in the medical field increases, so
does the probability of the silver nanoparticles interacting with human organs,
tissues, and cells (Chen & Schluesener, 2008). There are few studies of how
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silver nanoparticles interact with the different biological entities (organs, tissues
and cells) of the human body.
A case in point is the use of silver salt. Silver salt commonly has been
used in bone cement. In a 2004 study, the scientists looked at how silver salt
fought infections as opposed to how silver nanoparticles fought bacteria (Alt, et
al., 2004). Silver salts in polymethylmethacrylate (PMMA) bone cement were
found to be highly cytotoxic to osteoblasts (bone cells), but could still fight off
infections.

After using the silver nanoparticles, many of the infections were

reduced along with the reduction of the cytotoxic effects to osteoblasts. Figure 3
shows the differences in the cytotoxicity and antibacterial effects of the different
types of silver. As can be observed, the silver salts have both high antibacterial
properties and high cytotoxic effects: whereas, the silver nanoparticles have high
antibacterial effects and low cytotoxicity.

According to this study, the silver

nanoparticles are the better material to use since they show the lowest
cytotoxicity to osteoblasts.
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High

Cytotoxicity

Silver Salt Bone
Cement

Medium

Nanosilver Bone
Cement
Low

Medium

High

Anti-infective Activity

Figure 3. Overview of Cytotoxicity and Antibacterial Properties of Silver
Salts versus Nanosilver Use in Bone Cement (modified from Alt, et al.,
2004)

Silver nanoparticles can also be ingested into the body. Ingestion is a
common route of intake. Silver nanoparticles are found in ‘health maintainers’ or
‘immuno-boosters’, water disinfection products and food stabilization products
(Chen & Schluesener, 2008). These uses have increased the amount of silver
nanoparticles available to be ingested by the population. Increased ingestion
increases the availability of distribution of the nanoparticles to the cells. This
may also lead to a greater formation of ROS in cells, which, as stated earlier, can
lead to cell death. Without knowing the effects of the nanoparticles extensively,
the lethal limit cannot be known. Ingesting chronic doses of silver can lead to
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argyria whose most striking symptom is a bluish-grey skin color (Goyer &
Clarkson, 2001).
The concern for this study is the inhalation exposure effects. With the
increase in the industrial production, the general population involved may be
exposed to nanoparticles in the air. Knowing how this affects the lung cells will
be helpful in determining protective gear as well as the limits of exposure to
humans.
2.4. Surface Characteristics
The most important characteristic of a nanoparticle is its small size. This
small size allows for the increased surface area (to volume ratio) that is readily
available for reactions (Chen & Schluesener, 2008). It also allows for greater
particle mobility in the environment and the body. The small size gives way for
different entry points into the body:

ingestion, inhalation, and/or dermal

absorption. With respect to inhalation, the small size allows for the particulates
to make it through the nasal-pharyngeal region to the alveolar region of the
respiratory system. Particles smaller than 2.5 microns, generally, are able to
traverse into this region. Nanosilver may be able traverse through the nasal
pharyngeal region into the alveolar region. Once in this region, nanoparticles can
be distributed throughout the body (via the circulatory system, for example)
where they can initiate different types of tissue responses, such as: cell defense
activation, ROS generation, inflammation, and possibly cell death (Chen &
Schluesener, 2008). Chen also states that several studies have shown that the
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after inhalation of minute silver nanoparticle concentrations, the concentration in
the lungs diminishes quickly. Silver nanoparticles were consequently detected in
the blood and other organs (heart, liver, kidney, and brain) (2008). This is an
indicator of how quickly nanosilver can be distributed through the body from the
respiratory system to the circulatory system after inhalation.
The nanoparticles used during this research are either ‘coated’ or
‘uncoated’. According to Dr. Kyung Yu (2008) it is expected that the ‘uncoated’
nanoparticles are more toxic to cell mitochondrial activity than the respective
‘coated’ nanoparticles. The previous research on other nanoparticles has shown
that this is the case with the different nanoparticles that they have tested (Yu,
The ‘coated’ nanoparticles have a protective coat surrounding each

2008).

nanoparticle.

In this study, the ‘coated’ nanoparticles are coated with

polysaccharides.
2.5. Nanotoxicity and Bioterrorism
Nanoparticles can be inhaled, like aerosols. Aerosols can move through
the nasal-pharyngeal region, bronchial region, into the alveolar region, depending
on size.

After inhalation, nanoparticles can deposit throughout the entire

respiratory tract, starting in the nose and the pharynx, down to the lungs (Buzea
& Blandino, 2007).

Larger particles will naturally deposit in the nose and

pharynx, or at the branch points in the respiratory system. The smaller particles,
less than 2.5 microns, may make it through the lungs and alveolar region. With
nanoparticles, as small as they are, they can easily move into the alveolar region.
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The alveolar region has a very large surface area for nanoparticles to
interact upon. If these small nanoparticles move to the alveolar region, they can
be circulated throughout the body. They can then be found distributed through to
the heart, blood and other organs. Nanoparticles also can be found inside cells
after entering a biological entity (like organs). Once inside the cells, they can
enter the cytoplasm, mitochondria, lipid vesicles, the nucleus and other
organelles. Cellular uptake and capability to form oxidative products depend on
the particular nanoparticle chemistry, size and shape (Buzea & Blandino, 2007).
They can cause cell damage or even cell death.

In Figure 4, the different

pathways that nanoparticles may follow once inside the cells can be observed.
Nanoparticles not only can be inhaled, but also can penetrate through
dermal barriers or be ingested to enter the circulatory systems. Dermal exposure
can come through wound dressings. In a wound dressing, there is direct access
into the body through the wound. Once foreign entities enter into the circulatory
system, they can affect any part of the body, including the heart and the brain.
One concern for the ingestion of nanoparticles is through water contamination.
Animal ingestion of such contaminated products that have used these
contaminated systems can pose a threat potential to the population.
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Figure 4. Schematics of the molecular events by which nanoparticles (NP) exert
their toxic effects at the cellular level (modified from Buzea & Blandino, 2007)
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2.6. Cellular Assays
2.6.1. MTT Assay
The

MTT

(yellow

MTT

–

(3-(4,5-Dimethylthiazol-2-yl)-2,5

diphenyltetrazolium bromide)) assay measures the formation of formazan by
cells. This assay is a colorimetric test measuring the activity of enzymes that
reduce MTT to formazan which indicates cell viability at an absorbance reading
at 490nm. MTT also measures the cell mitochondrial activity where the reduction
to formazan takes place.

This conversion to formazan is often used as a

measure of viable (living) cells.
2.6.2. MTS Assay
The MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethophenyl)-2(4-sulfonyl)-2H-tetrazolium, inner salt) assay is a colorimetric method to identify
the cytotoxic potential of the nanoparticles and determine cell viability by reading
the absorbance at 490nm.

MTS is chemically reduced by cells to formazan

which is soluble in tissue culture medium. The assay measures dehydrogenase
enzyme activity found in metabolically active cells (Promega). In this chemical
process, reducing compounds (NADH or NADPH) pass electrons to an
intermediate electron transfer reagent that can reduce the tetrazolium product,
MTS, into an aqueous, soluble formazan product. Cells rapidly cannot reduce
tetrazolium products after death (Promega, 2006). The production of formazan is
proportional to the number of living cells; the intensity of the produced color is a
good indication of the viability of the cells (Promega). The initial color of the MTS
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solution is yellow. After incubation, the purple color produced is the formazan,
the indication of cell viability.
The MTS assay is being used more than MTT due to time of exposure and
amount of resources required. The use of DMSO for solublization of the MTT is
another reason that MTS is favored. The MTS assay requires a 96-well plate
which can be used to test more concentrations at once with only 200 µL of
solution needed per well. The MTT assay requires the use of either 6-well or 24well plates to accommodate the 0.5 mL of solution needed for each well. In this
study, the 6-well plates were used during the growth curve determination.
2.6.3. LDH Assay
The LDH assay is used to determine cell cytotoxicity by measuring the
lactose dehydrogenase (LDH) leakage across the plasma membrane. LDH is a
cytoplasmic enzyme that is released into the cytoplasm upon cell lysis
(Nanotechnology Characterization Laboratory, 2006). It is considered to be a
measure of membrane integrity.

Cells that lose membrane integrity release

lactate dehydrogenase. According to the Nanotechnology Characterization
Laboratory the basis of LDH assay is that:
1) LDH oxidizes lactate to pyruvate,
2) Pyruvate reacts with the tetrazolium salt INT to form formazan, and
3) The water-soluble formazan dye is detected spectrophotometrically
(2006).
The increase in the amount of formazan correlates directly to the increase in the
number of lysed cells (Biovision, 2008).
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2.6.4. Reactive Oxygen Species (ROS) Assay
Many studies, both in vivo and in vitro, have shown that nanoparticle
toxicity can induce the formation of reactive oxygen species. Reactive oxygen
species have been shown to damage cells by peroxidizing lipids, altering
proteins, disrupting DNA, interfering with signaling functions and modulating
gene transcription (Buzea & Blandino, 2007).

Oxidative stress can be a

response to cell injury. Generally, small amounts of ROS are made in the cell
through physiological processes, one of which is the electron transport chain
within the mitochondria. During this process, molecular oxygen is reduced one
electron at a time (Boelsterli, 2007). Figure 5 shows the stepwise reduction of
oxygen in cell mitochondria. Partially reduced oxygen species may break away
from the usual electron transfer process within the mitochondria (Boelsterli,
2007). This creates a steady small amount of ROS inside the cell. ROS are
generated within the cell to a degree through the reduction-oxidation cycling of
outside entities, xenobiotics (silver nanoparticles in this study). This occurs
through the separation of monooxygenases or by rerouting the electrons from the
electron transport chain (Boelsterli, 2007).

•O-O•

 O2•-  H2O2  HO•  H2O

Figure 5. Stepwise reduction of oxygen (modified from Boelsterli, 2007)
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Xenobiotics have been shown to increase the ROS production. They do this
through penetration into the mitochondria and interfering with the electron
transport chain, thus blocking normal electron flow (Boelsterli, 2007).

The

xenobiotics can also induce oxidative stress thereby causing the oxidation of the
nucleic acids within the cell. Figure 6 shows an overview of what happens within
the cell after the ROS have been formed.

The ROS induce the antioxidant

response of the cell, causing damage to DNA. The damaged DNA either repair
themselves or cause further damage to the cells.

ROS

Antioxidants
DNA

Repair

Oxidative Damage
To DNA
Apoptosis
Necrosis
Mutations

Figure 6. Oxidative DNA Damage Can Lead to Apoptosis
(Modified from Boelsterli, 2007)

Because of the mitochondria naturally generates ROS, the mitochondrial
DNA is more prone to have an oxidative event that may cause permanent
damage. The mitochondria also have ineffective repair mechanisms for ROS
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damage. As a result of this inefficiency, the mitochondrial DNA amass more
oxidatively damaged bases (Boelsterli, 2007). But there are numerous copies of
mitochondrial DNA and numerous mitochondria in the cell; this far outweighs the
general oxidative event that may occur to the mitochondria. When adding the
additional creation of ROS through a xenobiotic it can be expected that the
mitochondria will not be able to survive the mass amount of ROS production.
2.7. Current Research and Applications
Research in nanoparticles has increased dramatically over the last couple
decades. While all the applications of nanoparticles will not be mentioned, the
following applications show the wide array of products that nanoparticles are
being used in currently.
Products using nanoscale materials now available include: anti-bacterial
wound dressings (use nanoscale silver), water filtration, catalysis, dental bonding
agent, step assists on vans, bumpers and catalytic converters on cars,
sunscreens and cosmetics, and dry powder that can neutralize gas and liquid
toxins in chemical spills and elsewhere (National Nanotechnology Initiative,
2008). Research in nanomedicine, for instance, is focused on finding new ways
for diagnosing and treating disease (National Nanotechnology Initiative, 2008).
Inorganic nanoparticles generally possess versatile properties suitable for cellular
delivery, including a wide availability, rich functionality, good biocompatibility,
potential capability of targeted delivery, and controlled release of carried drugs
(Xu, Zeng, Lu, & Yu, 2006). Other uses are in carbon nanotubes (CNTs) and
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nanofilms (eyeglasses, computer displays, and cameras to protect or treat the
surfaces) (National Nanotechnology Initiative, 2008). Also, there is research that
incorporated the use of silver nanoparticles in fighting HIV. The researchers
found that silver nanoparticles undergo a size dependent interaction with human
immunodeficiency virus type 1 (Pal, Tak, & Song, 2007).

As seen with this

example and the bone cement study, medical research is an important sector of
the nanotechnology development.
There are few studies look at the interaction of silver nanoparticles and
their biodistribution and organ accumulation, as well as the tissue interaction and
toxicological implications (Chen & Schluesener, 2008), but the field is growing.
Studies still need to be completed on the transdermal considerations of
nanosilver toxicity especially since they have use in the clothing industry (socks)
and the medical field (wound dressings).
Lastly, the DoD, in conjunction with the ISN, is looking at improving
Soldier survivability in the field/wartime environments. The development of a suit
that is self contained and can detect and protect from chemical or biological
weapons of mass destruction is on their developmental horizon (PennWell
Corporation, 2003).
2.8. Summary
Silver nanoparticles are beginning to, and have begun to be used in many
products. Not only are these nanoparticles being used by civilians, but also, the
Department of Defense has begun researching its own applications for silver and
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other nanoparticles.

With so few studies showing how these nanoparticles

interact biologically in humans, it cannot be understood what the potential risks
may be. Research of this nature can assist in the building blocks of learning how
these nanoparticles may interact biologically in humans. This study begins to
look at how silver nanoparticles interact with human lung cells.
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III. Methodology
3.1. Introduction
The goal of this research was to determine if silver nanoparticles are toxic
to human lung epithelial cells. This was carried out through in vitro methods that
initially used MTS assays to determine mitochondrial activity and cell viability.
LDH assays were used to determine the membrane leakage of the cells. ROS
assays were conducted to determine the presence or evolution of reactive
oxygen species in the cell line. Each assay required cell culturing and splitting
prior to starting. Therefore, the assays were started on a day which cell splitting
was completed.
Each assay used a positive control solution that either was another
nanoparticle solution (MTS and LDH) or hydrogen peroxide solution (ROS). The
positive control was used to monitor the assays for proper readings, as well as to
ensure that they were working in the method that was expected. By comparing
the results of the positive control to the nanoparticle readings, it could be
determined if the assay was working properly for each trial.
Each assay was completed in triplicate to conduct statistical analysis. The
steps for cell culturing, growth curve determination and each separate assay are
listed in detail in Appendices A-F.
Along with the assays previously listed, Dynamic Light Scattering (DLS),
Transmission Electron Microscopy (TEM), and CytoViva™ characterization
analyses were performed on the cells and/or the different silver nanoparticles.
These results are also shown in this chapter.
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3.2. Assumptions
There are several key assumptions that were made prior to the
experimental process.
1. An equal distribution of silver nanoparticles occurs after cell dosing,
giving equal exposure to each nanoparticle to epithelial cells.
2. Cells dosed at the same concentration of silver nanoparticles each
receive the same level of exposure throughout each assay.
3. In vitro studies can give insight to in vivo studies.
3.3. Cell Lines
The cells used during this experiment were from the American Type
Culture Collection (ATCC) (Manassas, VA), Number CCL-185, Designation
A549. The A549 cell line is from human lung epithelial (carcinoma) cells, with an
initial isolation date in 1972.

These cells were chosen to look at possible

inhalation exposure toxic effects upon the lungs.
3.4. Cell Culture and Splitting
A549 (ATCC) lung epithelial cells were cultured in accordance with the
ATCC Protocol found in Appendix A (ATCC, 2008). One change to the ATCC
protocol was to use a 5 mL rinse with Phosphate Buffer Solution (PBS) after the
initial aspiration.
confluence.

Cell splitting was conducted every three to four days at

Cell confluence was determined by observation through a light

microscope.
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3.4.1. Growth Curve
A549 cells were grown over a specified length of time to determine the
normal growth rate of the cells without nanoparticle interference. This experiment
started with a solution of 100,000 cells/mL in growth media. The cell growth was
monitored over seven days.

Each day the cells were counted to determine

growth change from day to day using a standard hemocytometer and light
microscope. Along with the cell counting, a cell viability assay was conducted.
The MTT assay was used to determine the viability of the cells each day using an
absorbance reading at 490 nm. The blank measurement used for this assay was
acidified-isopropyl alcohol (IPA). A growth curve was determined using the data
from the daily cell counts. A full outline of the procedure is found in Appendix B.
3.5. Absorbance and Fluorescence Readings
The absorbance of the materials was read on a Biotek® Synergy HT plate
reader. The readings were taken at 490 nm for MTT, MTS, and LDH Assays.
The ROS fluorescence was read at an excitation wavelength of 485 ± 20 nm and
an emission wavelength of 528 ± 20 nm from the bottom of the plate.

The

results were exported into a Microsoft® Excel spreadsheet for calculations.
3.6. Nanoparticles
The nanoparticles were received from Clarkson University. The coating
on the ‘coated’ nanoparticles is a polysaccharide coating. Table 2 shows the
different types and concentrations of silver nanoparticles used throughout this
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experiment. The nanoparticle solutions were made in exposure media.

The

exposure media for the MTS and LDH assays were the same. The exposure
media used during the ROS assay was a colorless version of exposure media
(discussed in Section 4.2.5.). These concentrations indicated in Table 2 were
used during the MTS, LDH and ROS assays.

Table 2 Expe.rimental Nanoparticle Sizes and Concentrations

Nanoparticles

Control

Coated
(5 nm & 80 nm)
Uncoated
(10 nm & 80 nm)

0 µg/mL

Dosing Concentrations
(µg of nanoparticle per mL of solution)
10 µg/mL
50 µg/mL 100 µg/mL 200 µg/mL

0 µg/mL

10 µg/mL

50 µg/mL

100 µg/mL

200 µg/mL

In Figure 7, the nanoparticle solutions have been made for dosing 96-well
plates for an assay. From left to right are: uncoated 5 nm, uncoated 80 nm,
coated 10 nm, and coated 80 nm in the dilutions given above in Table 2. From
closest to furthest in columns are dilutions of 10 µg/mL, 50 µg/mL, 100 µg/mL,
and 200 µg/mL.
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Figure 7. Nanoparticle Solutions Prepared for Dosing Plates

3.7. MTT Assay
The MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5 diphenyltetrazolium bromide)
assay was used to determine the viability of the cells by reading the absorbance
reading at 490 nm. The control was acidified-isopropyl alcohol (IPA). It is a
colorimetric test used to measure activity of enzymes that reduce MTT for
formazan (yields a purple color). The initial color of the MTT solution is yellow.
After incubation the reaction yields a purple color of the solution. The intensity of
the color indicates the amount of viable cells.

This assay was completed in

accordance with Appendix C. The absorbance was read on a Biotek® Synergy
HT Plate reader. The results were exported to and graphed on Microsoft® Excel
software.
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This assay was used during the growth curve determination. It was used
to determine the viability of the cells during the growth curve only. The MTS
assay was used for all calculations and determinations of cell viability during the
rest of the study.
MTT solutions were kept in light protected vials in a refrigerator at 4°C.
The MTT solution was made by dissolving 10 mg of MTT powder into 20 mL of
PBS.
3.8. MTS Assay
The

MTS

(3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethophenyl)-2-(4-

sulfonyl)-2H-tetrazolium, inner salt) (Promega, 2006) assay is a colorimetric
method to identify the cytotoxic potential of the nanoparticles and determine cell
viability using an absorbance reading at 490 nm. The MTS solution (Promega,
CellTiter 96® AQueous One Solution Reagent) starts as a yellow solution. After
incubation, dependent on the amount of viable cells, the solution changes to a
purple color.

The intensity indicates viability. This procedure was done in

accordance with Appendix D and completed in triplicate. The control medium
used was exposure media. The positive control used was a Cadmium Dioxide
nanoparticle solution. The absorbance was read on a Biotek® Synergy HT Plate
reader at 490 nm. The results were exported to and graphed using Microsoft®
Excel software.
MTS solutions were kept in light protected vials in a refrigerator at 4°C.
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3.9. LDH Assay
The LDH assay was used to determine cell cytotoxcity through measuring
the lactose dehydrogenase leakage across the plasma membrane.

This

procedure was completed in accordance with Appendix E and the Promega®
protocol. The control used was exposure media. The positive control used was
a Cadmium Dioxide solution in exposure media. The absorbance was read at
490 nm on a Biotek® Synergy HT Plate reader. The results were exported to
and graphed on Microsoft® Excel software.
3.10. Reactive Oxygen Species (ROS) Assay
The ROS assay measures the formation of reactive oxygen species by
nanoparticle interaction in the cells. The procedure references the methods used
in Wang & Joseph (1999) and can be found in detail in Appendix F. This method
uses DCFH-DA (2’,7’– dichlolorodihydrofluorescein diacetate).

The theory

behind using DCFH-DA is that the non-fluorescent fluorescin derivatives will emit
fluorescence after being oxidized (Wang & Joseph, 1999). During this assay,
hydrogen peroxide was used as the positive control. After being applied to intact
cells, the non-ionic, nonpolar DCFH-DA crosses cell membranes and is
hydrolyzed enzymatically by intracellular esterases to nonfluorescent DCFH. In
the presences of reactive oxygen species, DCFH is oxidized to highly fluorescent
dichlorofluorescein (DCF) (Wang & Joseph, 1999).
The fluorescence of the cells was read on a Biotek® Synergy HT plate
reader. The excitation filter was set at 485 ± 20 nm and the emission filter was
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set at 528 ± 20 nm and set to read the plate from the bottom. The results were
exported to and graphed on Microsoft® Excel Software.
3.11. Dynamic Light Scattering and Transmission Electron Microscopy
Transmission electron microscopy (TEM) characterization was performed
to obtain nanoparticle size and morphology on a Hitachi H-7600 tungsten-tip
instrument at an accelerating voltage of 100 kV. Nanoparticles were examined
after suspension in water (1 mg/mL) and subsequent deposition onto
formvar/carbon-coated TEM grids (~10 µL).

Image J was used to measure

nanoparticles after TEM imaging with proper scale calibration. Information on
mean size and standard deviation was calculated from measuring over 100
nanoparticles in random fields of view in addition to images that show general
morphology of the nanoparticles.

Mr. Craig Murdock performed all TEM

measurement analysis during this research.
Dynamic light scattering (DLS) (for characterization of nanomaterial size
or agglomeration of the nanoparticles in solution) was performed on a Malvern
Instruments Zetasizer Nano-ZS instrument.

The device uses a 4mW He-Ne

633nm laser to analyze the samples. Samples were prepared as previously
described above in the TEM section and vortexed to provide a homogeneous
solution, and then 1.5 mL was transferred to a square cuvette for DLS
measurements.

Solutions were made at a concentration of 50 μg/mL for

measurement. The Malvern Zetasizer Nano-ZS uses the Dispersion Technology
Software (V4.20) for data collection and analysis. The mean particle diameter is
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calculated by the software from the particle distributions measured and the
polydispersity index (PdI) given is a measure of the size ranges present in the
solution (Malvern Instruments Ltd., 2005). The PdI scale ranges from 0 to 1, with
0 being monodisperse and 1 being polydisperse. The software calculates the
PdI value from the G1 correlation function and from parameters defined in the
ISO standard document 13321:1996 E. Mr. Craig Murdock performed all DLS
measurement analysis during this research.
3.12. CytoViva™
After counting the cells, a solution of 150,000 cells/mL was made in
growth media. One milliliter of the solution was added to each half of a twochamber polystyrene vessel culture slide, tissue culture treated glass slides (BD
Falcon). The slides were then incubated for 24 hours at 37°C.
After 24 hours of incubation, the slides were aspirated and washed with
1mL of PBS. A 10 µg/mL dosing solution was prepared for each nanoparticle
type (Uncoated 5 nm and 80 nm; Coated 10 nm and 80 nm).

One milliliter of

each nanoparticle solution was added to the appropriate slide. The slides were
then incubated for 24 hours. One milliliter of exposure media (F-12K Medium,
Kaighn’s Modification of Ham’s F-12 with 1% Penicillin/Streptomycin) was used
in the control slide. The slides were then incubated for 24 hours at 37°C.
After 24 hours of incubation, the media was aspirated from the culture
slides and washed with 1 mL of 1xPBS. The PBS was aspirated from the slides.
Then, the chambers were removed from the slides. Seven microliters of PBS

39

was added to each side of the slide and covered with a cover slip. The cells were
evaluated (on glass slides with cover slips) using the 60x oil lens and were
imaged with an Olympus IX71 Microscope platform coupled to the CytoViva™
150 Ultra Resolution Imaging (URI) System, as described in a study by Skebo et
al. (Skebo, Grabinski, Schrand, Schlager, & Hussain, 2007).

The QImaging

Retiga 4000R and QCapture Pro Imaging Software 6.0 were used to capture and
store images. Mr. Craig Murdock performed the CytoViva™ analysis.
3.13. Statistical Analysis
After reading either the absorbance or fluorescence, the data was
downloaded to Microsoft Excel for statistical analysis.
completed in triplicate.

Each assay was

The data was transferred to SYS-STAT (statistical

software) to determine statistical changes for all data compiled for the MTS and
LDH assays.

Results for the ROS assay were analyzed using a one-way

analysis of variance with Bonferroni multiple comparisons using SYS-9 statistical
software. Statistical significance for all assays was determined using a 95%
confidence interval.
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IV. Data Description and Analysis
4.1. Introduction
This chapter presents the data gathered from the methodologies
described in Chapter 3. The data includes: the growth curve, MTS assay (24,
48, and 72 hour trials), LDH assay (24, 48, and 72 hour trials), and ROS assay
(1, 4, 6, and 24 hour trials). Also, the results from the TEM, DLS and Cyto-Viva
are shown. The MTS and LDH assays show the respective combined results
after 48 hours of exposure to nanoparticles. The 48 hour exposure timeframe
was determined to be the most reliable time for these assays. The ROS assay
data includes the time data for each nanoparticle type and the compiled time
data from the three trials. The TEM, DLS, and Cyto-Viva show the nanoparticles
in solution and with the A549 cell line.
After compiling the data and observing initial trends and values in
Microsoft Excel, the data was entered into the SYS-STAT (MTS) or SYS-9 (ROS)
program.

This program performed the statistical analysis of the data sets. The

p-value was set to p < 0.05. The SYS-STAT program was used to statistically
determine significant differences between data sets. The program also identified
outliers within any data sets.
4.2. Results
4.2.1. Growth Curve
The goal of the growth curve was to determine how many days it would
take to grow 1,000,000 cells/mL starting with 100,000 cells/mL (in growth media).
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To determine this, seven 6-well plates were seeded with 0.5 mL per well of a
100,000 cells/mL solution of A549 cells (in growth media) on day zero. There
was one plate for each day for the duration of the growth curve. Each day the
cells were counted and an MTT assay was performed in accordance with
Appendix B. At day four, the growth media was changed in each remaining plate
to ensure growth. The data for the daily cell count and log of the daily cell count
is seen in Table 3. The growth curve was plotted on a logarithmic curve over
seven days of growth as can be seen in Figure 8. It was determined that it would
take about seven days to grow the cells by one factor of 10.

Log A549 Growth Curve
6.5

Day
Log A549 Cell Count

6.0
y = 0.5592ln(x) + 4.9674
R² = 0.9275
5.5
Log A549 Growth Curve
5.0
Log. (Log A549 Growth
Curve)
4.5

4.0
1

2

3

4

5

6

7

Days of Growth

Figure 8. Seven Day Growth Curve with Trend Line
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1
2
3
4
7

Count
Log Count
100000
5.0000
205000
5.3118
267500
5.4273
830000
5.9191
957500
5.9811

Figure 8 shows the greatest growth rate occurred between days three and four
and shows a plateau effect between days four and seven. The data for the
number of cells is not known for days five and six for the number of cells, but still
can be interpolated through Figure 8.
4.2.3. MTS Assay
Silver nanoparticles are known to interfere with the absorbance readings.
Therefore, 80 µL of supernatant was removed from the dosed plate (from each
well) and placed in new plate to read the absorbance at 490 nm without
interference from nanoparticles in solution.

Initially, a preliminary trial was

completed at 24 hours of nanoparticle exposure, 48 hours of nanoparticle
exposure, and 72 hours of nanoparticle exposure. This was done to determine
the best exposure duration. It was determined from those results, that 48 hours
of exposure to nanoparticles was the best fit for the amount of exposure time.
Figures 9 through 11 show the data compiled from the different time trials
conducted: 24, 48, and 72 hours, respectively.
The 24 hour exposure time did not show a strong response through the
absorbance change from the control (% MTS reduction) during the assay. The
difference from the control medium was not significant enough at this time frame
at all nanoparticle solutions. Only the uncoated 5nm showed a strong change in
absorbance with increasing concentration. The difference from the control was
generally less than 20% reduction across the board (except with the uncoated, 5
nm – 200 µg/mL solution), as can be seen with Figure 9.
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This time trial also

showed variance from what was expected to occur during this assay. Instead of
a steady decrease across the concentrations for each nanoparticle type, some
increased with respect to percent control MTS reduction.

MTS Assay (24 hours): Ag Nanoparticle Concentration vs.
MTS Reduction Absorbance (490nm)
140.00

MTS Reduction (% Control)

120.00

100.00

80.00
Uncoated 5nm Ag
Uncoated 80nm Ag

60.00

Coated 10nm Ag

Coated 80nm Ag

40.00

20.00

0.00
Control

10

50

100

200

Ag Nanoparticle Concentration (µg/mL)

Figure 9. MTS Assay - 24 Hour Exposure

The 48 hour exposure time trial results are shown in Figure 10. The 48
hour exposure time trial showed that the lung cells were exposed to the toxic
effects of the nanoparticles for the appropriate duration. There was a significant
change of the toxicity over time without the cell death effect seen in the 72 hour
trial. The trend showed what was expected with respect to concentration
dependent toxicity; a steady decrease across increasing concentrations for each
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nanoparticle.

It can be observed that as the concentration of the separate

nanoparticles increase, so does the toxicity to the cells. Also, in this time trial, as
opposed to the 72 hour trial, there appeared to be enough viable cells remaining
at all concentrations of each nanoparticle to expect that this would be the case
during the further testing at this exposure duration.

MTS Assay (48 hours): Ag Nanoparticle Concentration vs.
MTS Reduction Absorbance (490nm)
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MTS Reduction (% Control)
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20.00

0.00
Control
-20.00
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Ag Nanoparticle Concentration (µg/mL)

Figure 10. MTS Assay - 48 Hour Exposure

The 72 hour exposure time trial indicated that the cells received too
extensive an exposure from the nanoparticles, as can be seen in Figure 11. The
cells were essentially killed by the length of nanoparticle exposure at the 100 and
200 µg/mL concentrations. The 50 µg/mL concentration for both uncoated
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nanoparticles sizes showed similar results, indicating cell death at this
concentration. Because of this increased cell death, when compared to the other
two time trials and due to exposure length, this was determined not to be the
optimal duration to expose the cells to the nanoparticles.

MTS Assay (72 hours): Ag Nanoparticle Concentration vs.
MTS Reduction Absorbance (490nm)
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Figure 11. MTS Assay - 72 Hour Exposure

After determining that 48 hours was the best timeframe, the results were
compiled from three trials at this time of nanoparticle exposure. The results from
the separate trials are in Figure 12.

The concentration dependence of the

nanoparticle toxicity can be observed. As the concentration increases from 0
µg/mL to 200 µg/mL, the MTS reduction percentage decreases. This indicates
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that the mitochondrial function of the cells decreased. This is shown through the
Percent MTS Reduction of the formazan in the cells. The mitochondria were not
available for the reduction, which implies that cell death had occurred.
With respect to nanoparticle size affecting toxicity, it is observed that the
larger of the nanoparticles, in the coated and uncoated category, tended to be
less toxic than its smaller counterpart. The uncoated 5nm silver nanoparticles
showed the greatest toxicity to the human lung cells, with essentially complete
cell death at 200 µg/mL concentrations.

The uncoated 80nm concentrations

showed less toxicity than the uncoated 5nm. The uncoated 80nm showed about
1.5 times less toxicity at the higher two concentrations than its 5nm counterpart.
The coated nanoparticles, both 10nm and 80nm, showed approximately equal
toxicity at the 200µg/mL concentrations. The toxicity of the coated nanoparticles
remained within a range of 10% MTS reduction percentage of each other at each
different concentration.
Another significant difference in the MTS reduction assay was the
difference between the coated and uncoated nanoparticles.

The uncoated

nanoparticles clearly show more toxicity than the coated nanoparticles, as can be
observed in Figure 12. With the two larger nanoparticles, 80nm, the coated
remained about 15-20% greater MTS reduction than its uncoated counterpart
through the differing nanoparticle concentrations. This indicated that the coated
nanoparticle is less toxic to the cells than the uncoated nanoparticles.
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MTS Assay - 48 Hour Exposure
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Figure 12. Combined MTS Assay Results - 48 Hour Exposure – (*) indicate statistically
significant variation from the control

With the two smaller nanoparticles (5 and 10 nm), the uncoated
nanoparticle (5 nm) begins with a 10% decrease difference in MTS reduction at
10 µg/mL with respect to the 10 nm coated at the same concentration. At the 50
µg/mL concentration, this difference more than doubles to almost 25% decrease
difference in MTS reduction. The difference between the MTS reduction still
increases at the 100 µg/mL to approximately a 40% MTS reduction decrease
difference with the uncoated 5 nm showing increased toxicity with the increased
concentration. The uncoated 5 nm indicated almost complete cell death by the
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200 µg/mL concentration, whereas the 10nm coated indicated that about half the
cells were still viable at the same concentration.
The stars indicate where there is a statistically significant difference
between the results of the nanoparticle effects with respect to the control
(ρ<0.05). The uncoated 5nm silver nanoparticles show significant toxic effects at
concentrations greater than or equal to 50 µg/mL. The uncoated 80nm silver
nanoparticles show significant toxicity at concentrations greater than or equal to
100 µg/mL. The coated nanoparticles, both 10nm and 80nm, require at least 200
µg/mL before significant toxicity occurs to the lung epithelial cells.
4.2.4. LDH Assay
Like the MTS assay, silver nanoparticles have shown to interfere with the
absorbance readings. Therefore, 80 µL of supernatant was removed from the
dosed plate (from each well) and placed in new plate to read the absorbance at
490nm without interference from nanoparticles in solution.

This assay was

completed in conjunction with the MTS assays. Appendix E describes the step
by step instruction of this assay.
Initially, a preliminary trial was completed at 24 hours, 48 hours, and 72
hours of nanoparticle exposure. This was done to determine the best exposure
duration. It was determined from those results that 48 hours of exposure to
nanoparticles was to be used for the exposure duration. Figures 13 through 15
show the data compiled from the different time trials conducted: 24, 48, and 72
hours, respectively. It was expected that, if the MTS assay showed greatest
toxicity at the highest concentrations (low MTS reduction); then, the LDH assay
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should indicate high leakage (% LDH leakage to media) at corresponding
concentrations.
The 24 hour time trial was not chosen as the optimal amount of exposure
time for this assay, because the response from the absorbance was minimal. As
seen in Figure 13, the leakage percentage was minimal across the nanoparticle
concentrations, except for the uncoated 5 nm nanoparticles. Further exposure
was needed to achieve the expected result. As the nanoparticle concentration
increased, it would be expected that the LDH leakage into the media would also
increase. The 24 hours of exposure time trial did not show this to be the result
for all nanoparticles, as seen in Figure 13.

LDH Assay (24 hours): Ag Nanoparticle Concentration vs.
LDH Leakage Absorbance(490nm)
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Figure 13. LDH Assay - 24 Hour Exposure
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The 48 hour time trial was chosen as the amount of time to expose the
lung cells. The results of this time trial are found in Figure 14. Although it still did
not show the concentration dependent increase in LDH leakage, this assay was
completed with the MTS assay which was completed after 48 hours of exposure.
The equal time of nanoparticle exposure also was needed for an equal
comparison of results between the LDH and MTS assays.

LDH Assay (48 hours): Ag Nanoparticle Concentration vs.
LDH Leakage Absorbance (490nm)
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Figure 14. LDH Assay - 48 Hour Exposure

The 72 hour trial also did not show a concentration dependent increase in
LDH leakage. Figure 15 shows the data from the 72 hour time trial. There was
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no significant change in the absorbance at any nanoparticle concentration. This
exposure time was not chosen due to this.

LDH Assay (72 hours): Ag Nanoparticle Concentration vs.
LDH Leakage Absorbance (490nm)
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Figure 15: LDH Assay - 72 Hour Exposure

Three separate trials were completed with the 48 hour nanoparticle
exposure.

The 48 hour time point was chosen to have a direct comparison to

the MTS assay. The results of the 48 hour exposure trials are graphed in Figure
16.

Again, it was observed that the LDH leakage is decreasing across the

concentrations instead of increasing. From other trials on different nanoparticles,
it was expected that as the concentration of the nanoparticle solution increased,
so would the percent leakage of LDH into the media. This would be an indicator
of the toxicity of the nanoparticles to the cell membrane.
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LDH Assay - 48 hour Exposure
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Figure 16. Combined LDH Assay Results - 48 Hour Exposure

Because the results were not what would be expected with this type of
assay, it was determined that this was not a reliable assay to determine toxicity
of the silver nanoparticles with this cell line. It is suspected that the nanoparticles
may interfere with the LDH media or the LDH enzyme with the A549 cells. Also,
it can be inferred that the silver nanoparticles are killing the lung cells; therefore
there is no leakage of the LDH to the media occurring. This can be inferred while
comparing the MTS results to the LDH results. It is observed through the MTS
assay that there was increased cell death occurring at the higher concentrations
of silver nanoparticles.

53

4.2.5. ROS Assay
The exposure media and growth media used for the ROS testing is
different than the media used in the other assays. The media used during this
testing have no phenol red coloring in them.

The phenol red has been

associated with interference with the fluorescence readings required for this type
of testing. Therefore, in order to have a ‘clean’ reading, media without phenol
red is needed. The details of these solution are described in Appendix F.
Trials were completed after initial dosing (0 hour), 1 hour, 4 hours, 6
hours, and 24 hours. The procedure used was adapted from in Wang & Joseph
(1999) and described in Appendix F. Instead of reading the same plate for all
readings as indicated in their procedure, one 96-well plate was prepared for each
time point. Figure 17 shows an example of a black well plate after 1 hour of
incubation.

Figure 17. 96-Well Black Plate for ROS Assay after 1 Hour Incubation
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After an initial fluorescence reading of each plate, 80 µL of supernatant
was transferred from the original plate to a new plate to be read without the
nanoparticle interference. Three trials at each time point were completed. The
data was compiled by time point and each different nanoparticle type. Figures
18-21 show the compiled results of the 3 separate ROS trials by each different
nanoparticle type at each time point that a reading was taken.
Figure 18 shows the results from the uncoated 5nm silver nanoparticle for
the ROS assay. It shows that there is a 3-fold increase with respect to the
control (fluorescence).

The ROS formation peaked at this time point and

steadily decreased with increase exposure time.

There is also an inverse

proportionality between the nanoparticle concentration and ROS formation: the
lower the concentration, the higher the formation of ROS in the cell line. A higher
ROS fluorescence reading is observed at the lower concentration of the
uncoated 5nm than at the higher concentration. At all time points after the initial
reading, fluorescence indicates that ROS have been formed at all concentrations.
At 10 µg/mL, the uncoated 5nm nanoparticles show that they form ROS as
quickly as one hour after dosing the cells.
After conducting statistical analysis on the data, it was determined that
there were only two significant peaks; at 1 hour and with the 10 and 50 µg/mL
concentrations. Other peaks did not show statistical differences. This is due to
the range that the results of each (of the other) peak spanned. The standard
deviation of the data and the data means did not give statistical differences with
the control means.
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Fluorescence (Fold Difference)

Uncoated 5 nm Ag Nanoparticle Compiled
ROS Results
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Figure 18. Reactive Oxygen Species Results for Uncoated 5 nm - (*) indicate statistically
significant variation from the control

Figure 19 shows the results for the coated 10 nm silver nanoparticles.
These nanoparticles do not show the same fold difference as the 5 nm silver
nanoparticles; however the coated 10 nm still shows that ROS are formed after
the cells are dosed with the nanoparticles. The coated 10 nm reach a peak at
about 2-fold the fluorescence of the control. The coated 10 nm show its greatest
fold difference with the control with the 50 µg/mL concentration at the 1 hour time
points, which is the only statistically significant peak for this nanoparticle. Other
peaks did not show statistical differences. This is due to the range that the
results of each (of the other) peak spanned. The standard deviation of the data
and the data means did not give statistical differences with the control means.
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Fluorescence (Fold Difference)
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Figure 19. Reactive Oxygen Species Results for Coated 10 nm - (*) indicate statistically
significant variation from the control

Figure 20 shows the results for the uncoated 80 nm silver nanoparticles.
Like the uncoated 5 nm silver nanoparticles, the lowest concentration indicated
that ROS formation occurred upon dosing the cells with the nanoparticle, though
only slightly (about 0.2-fold difference with control). For the 10 and 50 µg/mL
concentrations, the fold difference peaks out at 1.5 fold-difference (with respect
to the control) at the 1 hour time point and maintain around that value for both the
4 and 6 hour time points. The higher two concentrations, 100 and 200 µg/mL,
show peak fold-difference at the 24 hour time point.

At the higher

concentrations, it is observed that it takes longer to have significant change in
ROS concentration than with the lower concentration of the same nanoparticle.
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The only significant peak was at the 10 µg/mL with one hour of exposure. Other
peaks did not show statistical differences. This is due to the range that the
results of each (of the other) peak spanned. The standard deviation of the data
and the data means did not give statistical differences with the control means.

Fluorescence (Fold Difference)

Uncoated 80nm Ag Nanoparticle Compiled
ROS Results
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Figure 20. Reactive Oxygen Species Results Uncoated 80 nm - (*) indicate statistically
significant variation from the control

Figure 21 shows the results for the coated 80 nm silver nanoparticles.
The 80 nm coated nanoparticles show similar ROS formation results compared
with the uncoated 80 nm silver nanoparticles. Both 80 nm silver nanoparticles
show similar levels in ROS formation during the trials. They both have shown
similar maximums and minimums at the different time points.
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The larger

nanoparticles (80 nm) show less toxicity than the smaller respective
nanoparticles (5 and 10 nm).
After conducting statistical analysis on the data, it was determined that
there were no significant peaks. Other peaks did not show statistical differences.
This is due to the range that the results of each (of the other) peak spanned. The
variation of the data means did not give statistical differences with the control
means.

Coated 80nm Ag Nanoparticle Compiled ROS
Results
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Figure 21. Reactive Oxygen Species Assay Results for Coated 80 nm

Overall, the ROS assay indicates that the formation of ROS in the A549
cell line is dependent on nanoparticle size and concentration. The uncoated 5
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and coated 10 nm nanoparticles show a higher formation of ROS than either of
the 80 nm nanoparticles. This is an indication that the smaller nanoparticles are
more toxic than the larger respective nanoparticles. The concentration of the
nanoparticles affects the ROS formation.

With the 5 nm nanoparticles, the

lowest concentration shows the highest ROS formation; the ROS formation
(toxicity) decreases with an increasing concentration of the nanoparticle.
Similarly, the coated 10 nm has the highest ROS formation at 50 µg/mL, then the
levels of ROS formation decrease with increasing concentration.
After statistical analysis, no peaks for the coated 80nm silver
nanoparticles were determined to be statistically significant.
The statistical analysis for the ROS assay data were analyzed using a
one-way analysis of variance with Bonferroni multiple comparisons (Rosner,
1990). The statistical analysis was completed by Dr. Latha Narayanan using
SYS-9 software and a confidence interval of 95% (ρ < 0.05).
4.3. Dynamic Light Scattering and Transmission Electron Microscopy
Figure 22 shows the TEM primary particles size and distribution
determined from measurement of over 100 particles from random fields of view.
Dynamic Light Scattering (DLS) results are shown in Table 4. DLS z-average
particle diameter in solution and LDV zeta potential measurements were
measured at sample concentrations of 50 µg/mL of each different nanoparticle
used in this study.
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Figure 22. Transmission Electron Microscope Images of Ag Nanoparticles. Images were
taken at 100 kV and 100 kx magnification on a formvar-carbon coated Cu grid. (A) Ag 5 nm
uncoated. (B) Ag 80 nm uncoated. (C) Ag 10 nm coated. (D) Ag 80 nm coated

Table 4 shows the TEM primary particles size and distribution determined from
measurement of over 100 particles from random fields of view. It also shows the
DLS

z-average

particle

diameter in solution

and LDV

zeta

potential

measurements were measured at sample concentrations of 50 µg/mL of each
different nanoparticle used during this study. The results show the average size
of the silver nanoparticles.

The results show that the smaller nanoparticles,

coated 5 nm and uncoated 10 nm, are larger than the size given by the
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manufacturer. The 80 nm nanoparticles, coated and uncoated, results indicate
that they are smaller than the size given by the manufacturer. The DLS particle
diameter in solution indicates that there is little agglomeration in de-ionized
water, but an increase in agglomeration when the nanoparticles are in exposure
media.
Table 3. Characterization Data for Silver (Ag) Nanoparticles

Particle

Ag 5 nm UC
Ag 80 nm UC
Ag 10 nm C
Ag 80 nm C

TEM Mean Primary
Particle Diameter
(±SD) (nm)

8.9 ± 2.6
61.2 ± 15.6
14.7 ± 4.1
65.6 ± 24.0

DLS Z-Average Particle Diameter in
Solution (PdI) (nm)

LDV Zeta Potential of
Particle Surface
Charge (mV)

DI H2O

F-12K Media

DI H2O

30.6 (0.626)
68.8 (0.240)
38.7 (0.532)
142 (0.145)

1550 (0.272)
1710 (0.359)
1930 (0.615)
241 (0.400)

-45.9
-13.8
-37
-29

4.4. CytoViva™
After exposing the A549 cells to the nanoparticles, photos were taken of
the cells using the CytoViva™ method. A control sample was photographed of
the A549 cells in exposure media only, shown in Figure 23. Figure 24 shows the
cells interaction with the nanoparticles in exposure media. It can be observed
through these photos that the nanoparticles do interact with the cell membrane.
It is unclear through the use of this method whether the nanoparticles are inside
the cells interacting with the mitochondria and the nucleus. Other methods will
need to be conducted to determine those interactions.
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Figure 23. CytoViva™ Picture at 60X (60-times) magnification of the A549 Cells (10 µg/mL
solution)
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Figure 24. CytoViva™ Pictures at 60X (60 times) magnification of the Silver Nanoparticles
and the A549 Cell Line (10 µg/mL solution) – (A) Coated 10 nm, (B) Coated 80 nm, (C)
Uncoated 5 nm, (D) Uncoated 80 nm

4.5. Summary
The MTS assay is a reliable assay for determining toxicity of the silver
nanoparticles on the A549 cell line. The assay shows that there is both a size
and concentration dependence for the level of toxicity to the cell mitochondria.
The ROS assay also is a reliable assay for determining the formation of ROS by
the silver nanoparticles in the A549 cell line.
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It also shows a size and

concentration dependent toxicity.

Both assays show that the smaller

nanoparticles are more toxic to the cells than the larger nanoparticles. The MTS
assay shows increasing toxicity with increasing concentration. In contrast, the
ROS assay showed a higher formation of ROS with lower concentrations. Both
assays also indicated that the uncoated nanoparticles have a higher toxic effect
to the cells than the coated nanoparticles.

The LDH assay did not provide

reliable results for this cell line and the silver nanoparticles.
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V. Conclusions and Future Research Considerations
5.1. Overview
This study demonstrates that silver nanoparticles are toxic to epithelial
lung cells.

Uncoated nanoparticles appear to be more toxic than coated

nanoparticles to the lung cell mitochondria. The MTS assay indicates that, with
greater concentrations the toxic effects are greater.

Also, the MTS assay

indicates that the smaller nanoparticles appear to be more toxic than the larger
nanoparticles (5 or 10 nm vs. 80 nm) to the cell mitochondria.
The LDH assay was determined to be an unreliable assay to determine
toxicity for the silver nanoparticles for this cell line. There is an interference
occurring, that would need further investigation.
The ROS assay indicates that the silver nanoparticles do induce the
formation of ROS in the cell line. The smaller nanoparticles (uncoated 5 and
coated 10 nm) show a higher formation of the ROS in the cells, especially at the
lower concentrations 10 and 50 µg/mL.

At higher concentrations of these

nanoparticles, the ROS formation is lower. The larger nanoparticles, both coated
and uncoated 80 nm, show similar results for ROS formation with respect to folddifference.

Although lower than the smaller nanoparticles, they do show

formation of the ROS in the cell line.
Both the MTS assay and the ROS assay are reliable assays to determine
toxic effects of silver nanoparticles in this cell line.

The LDH assay was

determined to be unreliable during this study. Both the MTS and ROS assay can
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assist in determining toxic effects of the silver nanoparticles in human lung
epithelial cells.
Through this study, it can be inferred that there is a mechanism of toxicity
through mitochondrial function interference as well as through the formation of
ROS within the cell line.
5.2. Investigative Questions Answered
1. Are silver nanoparticles toxic to the A549 (ATCC) lung epithelial cells?
From the MTS assay, it can be interpreted that the silver nanoparticles
are, in fact toxic to the A549 lung epithelial cells. The silver nanoparticles affect
the mitochondrial activity within these cells negatively. Once the mitochondria in
the cells stop functioning, the cells begin to move to apoptosis.
One method in which the nanoparticles cause cells to begin apoptosis is
through the formation of reactive oxygen species. These ROS are toxic to the
cells and, through the ROS assay, it can be interpreted that the silver
nanoparticles cause toxicity to the cells through the formation of ROS. From the
results of the ROS assay, it can be determined that the uncoated nanoparticles
are more toxic to the cells than the coated nanoparticles. Also, that the smaller
of the nanoparticles, whether coated or uncoated, is more toxic to the cell line.
2. Does the exterior coating of the nanoparticles affect toxicity?
By looking at both the MTS assay and the ROS assay, it can be observed
that the coating of the nanoparticles does affect the toxicity of the nanoparticle.
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The MTS assay indicates that the uncoated nanoparticles are much more toxic
than the coated nanoparticles.
This is supported through the ROS assay results. It can be observed that
the uncoated nanoparticles are more toxic to the cell line than the uncoated
nanoparticles. This is more the case between the smaller of the two types of
nanoparticles (uncoated 5 nm and coated 10 nm), than for the 80 nm
nanoparticles. The 80 nm nanoparticles show similar formation of ROS with
respect to the fold difference with the control across all time points. With the
smaller nanoparticles, the uncoated 5 nm shows to have a higher formation of
ROS within the cell line, especially in the earlier time points.
3. Does the size difference of the nanoparticles affect toxicity?
By looking at the MTS assay, it is clear that the size of the nanoparticle
matters, with respect to its toxic effects. The smaller nanoparticles show a lower
percent MTS reduction than their larger counterpart at all concentrations.
This is also supported through the results of the ROS assay.

The ROS

assay shows that the uncoated 5 nm and coated 10 nm silver nanoparticles
induce a greater formation of ROS than the uncoated and coated 80 nm
nanoparticles.
5.3. Recommendations for Future Research
As the future of technology shifts into the greater use of the nanoparticles,
it is important to acknowledge that these nanoparticles can also cause toxic
effects to human health. Future research should include a more in-depth study
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into the mechanisms of toxicity. From this study, it can be inferred that toxic
mechanisms of silver nanoparticle are through interruption of mitochondrial
function as well as the formation of the ROS within the lung cells. The study of
lung cells is becoming increasingly important since the silver nanoparticles are
being used industrially more than ever; therefore, the inhalation exposure will be
increasing. Also, there are products on the market that are aerosol disinfectant
sprays that incorporate the use of silver nanoparticles as the disinfectant (Fauss,
2008).
The aerosol use of silver nanoparticles is increasing both in industrial
settings and in the public market, understanding the level at which the toxic
effects of silver nanoparticles are lethal will be more important than ever. This
can also include understanding how this will affect the world of bioterrorism, both
in defense and detection. As seen earlier, the DoD, ISN and MIT are delving into
the realm of nanoparticle use for the defense and detection. Silver nanoparticles
may be able to be used for these types of methods for the warfighter. The
knowledge base of its toxicity will need to be built further than its current state.
An assay that can be used in further studies is the apoptosis assay to
determine the concentrations and times that apoptosis is occurring. This can be
used instead of the LDH assay, which was unreliable in this study. Also, this
assay can assist in the further determination of the lethal concentration of silver
nanoparticles and at what time point that apoptosis of the cells may occur.
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Appendix A: Cell Culturing and Splitting

A549 Cell Line: Human lung epithelial cells, ATCC® (Manassas, VA)
Growth Media: F-12K Medium, Kaighn’s Modification of Ham’s F-12 with 10%
fetal bovine serum (FBS) and 1% Penicillin/Streptomycin (P/S) Solution, ATCC®
(Manassas, VA)
PBS: 1% Phosphate Buffer Serum
1. Aspirate culture medium from 75 mL flask.
2. Rinse with 5.0 mL PBS.
3. Aspirate PBS.
4. Add 2.0 mL 0.25% Trypsin with EDTA solution to flask ensuring complete
coverage of bottom of flask.
5. Incubate for 4-5 minutes in 37°C incubator, or until the cells have
unattached from the bottom of the flask (cells will appear spherical under a
light microscope).
6. Add 5.0 mL growth media to flask and break apart the cells by pipetting
the solution in and out of the pipette.
7. Count the cells using a standard hemocytometer and light microscope.
a. Pipette 10 µL of the cell solution onto the hemocytometer
b. Count cells in each quadrant under a light microscope. The
average count from all quadrants indicates the number of cells per
milliliter of solution times 104.
8. In a new flask add 1.0 mL of the cell culture to 10.0 mL of growth media.
Incubate 3-4 days at 37°C.
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Appendix B: Cell Growth Curve Procedure

Acidified IPA: solution of 198.36 mL d-H2O, 1.64 mL concentrated hydrochloric
acid (HCl), and 300 mL Isopropyl Alcohol
MTT Solution: 10 mg MTT powder dissolved in 20 mL PBS
1. This procedure is started on a day when the cells are split.
2. In a 6 well culture plate (one for each day of the growth curve duration),
add 0.5 mL of a 50,000 cells/mL solution.
3. Incubate

each

plate

for

the

number

of

hours/days

indicated

(24hours/1day, 48hours/2days, etc.).
4. On the day that the plate is read:
a. For wells 1-3:
i. Aspirate media.
ii. Wash each well with 0.5 mL PBS, then aspirate PBS.
iii. Add 0.25% Trypsin with EDTA solution, incubate 4 - 5
minutes.
iv. Add 0.5 mL Growth Media to each well, break cells using a
pipette.
v. Mix all 3 wells in a vial and count cells using a
hemocytometer.
b. For wells 4-6
i. Aspirate media.
ii. Wash with 0.5 mL PBS and then aspirate PBS.
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iii. Add 0.5 mL of MTT Solution to each well, incubate 30
minutes.
iv. Aspirate media. Add 0.5 mL of Acidified IPA to each well.
v. Shake the plate vigorously for 10 minutes on shaker.
vi. Remove 200 µL into a 96-well plate to read absorbance at
490 nm.
5. Record the Cell Count and Absorbance.
6. Repeat as needed over the duration of the Growth Curve Period.
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Appendix C: MTT Assay
Exposure Media: F-12K Medium, Kaighn’s Modification of Ham’s F-12 with 1%
Penicillin/Streptomycin (P/S), ATCC® (Manassas, VA)
Acidified IPA: solution of 198.36 mL d-H2O, 1.64 mL concentrated hydrochloric
acid (HCl), and 300 mL Isopropyl Alcohol
MTT Solution: 10 mg MTT powder dissolved in 20 mL PBS
Day 1: Seeding the Cells
1. Follow the procedure for cell culturing.
2. After counting the cells, make a solution that has 200,000 cells/mL in
growth media.
3. In a 24 well plate, add 0.5 mL to each well that is being used. Each well
was marked with which type of nanoparticle and the dilution factor.
4. Incubate at 37°C for 24 hours.

Table 4. Example of 24-well MTT Plate

A
B
C
D

1

2

3

4

5

6

BLK

5nm Unctd
100ug/mL
5nm Unctd
100ug/mL
5nm Unctd
100ug/mL
5nm Unctd
100ug/mL

5nm Unctd
200ug/mL
5nm Unctd
200ug/mL
5nm Unctd
200ug/mL
5nm Unctd
200ug/mL

BLK

80nm Uctd
100ug/mL
80nm Uctd
100ug/mL
80nm Uctd
100ug/mL
80nm Uctd
100ug/mL

80nm Uctd
200ug/mL
80nm Uctd
200ug/mL
80nm Uctd
200ug/mL
80nm Uctd
200ug/mL

BLK
BLK
BLK

73

BLK
BLK
BLK

Day 2: Dosing the Cells
1. Aspirate media from the wells and wash with 0.5 mL per well with PBS.
2. Aspirate PBS.
3. Before adding nanoparticles into solution, sonicate for 10 seconds.
4. Add 0.5 mL of each nanoparticle dosing solution into the appropriate well.
Use exposure media to wells with 0 µg/mL nanoparticle solution.
Day 3: MTT
1. Ensure MTT Solution is at room temperature before using.
2. Aspirate media from wells and wash with 0.5 mL per well with PBS.
3. Add 0.5 mL of MTT solution to each well.
4. Cover plates and incubate for 30 minutes for color change.
5. Aspirate media.
6. Add 0.5 mL per well of acidified IPA. Place covered on shaker for 10
minutes to ensure that everything is in solution.
7. Remove 200 µL from each well and transfer to 96 well plate.
8. Read absorbance at 490 nm.
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Appendix D: MTS Assay
Exposure Media: F-12K Medium, Kaighn’s Modification of Ham’s F-12 with 1%
Penicillin/Streptomycin (P/S), ATCC® (Manassas, VA)
MTS Solution: CellTiter96® AQueous One Solution Reagent for the CellTiter 96®
AQueous One Solution Cell Proliferation Assay from Promega
Day 1: Seeding the cells
1. Follow the procedure for cell culturing.
2. After counting the cells, make a 23.0 mL solution that has 200,000
cells/mL in growth media.
3. In a 96 well plate, add 200 µL of the cell solution to each well that is being
used.

Each well should be marked with which type of nanoparticle and the

dilution factor.
4. Incubate at 37°C for 24 hours.
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Table 5. Example of a 96-Well Plate

1

2

A

blank

B

blank

C

blank

D

blank

E

blank

F

blank

G

blank

H

blank

3
10ug/mL
5nm, uc
10ug/mL
5nm, uc
10ug/mL
5nm, uc
10ug/mL
5nm, uc
10ug/mL
80nm, uc
10ug/mL
80nm, uc
10ug/mL
80nm, uc
10ug/mL
80nm, uc

4
50ug/mL
5nm, uc
50ug/mL
5nm, uc
50ug/mL
5nm, uc
50ug/mL
5nm, uc
50ug/mL
80nm, uc
50ug/mL
80nm, uc
50ug/mL
80nm, uc
50ug/mL
80nm, uc

5
6
100ug/mL 200ug/mL
5nm, uc 5nm, uc blank
100ug/mL 200ug/mL
5nm, uc 5nm, uc blank
100ug/mL 200ug/mL
5nm, uc 5nm, uc blank
100ug/mL 200ug/mL
5nm, uc 5nm, uc blank
100ug/mL 200ug/mL
80nm, uc 80nm, uc blank
100ug/mL 200ug/mL
80nm, uc 80nm, uc blank
100ug/mL 200ug/mL
80nm, uc 80nm, uc blank
100ug/mL 200ug/mL
80nm, uc 80nm, uc blank

7

8
10ug/mL
10nm, c
10ug/mL
10nm, c
10ug/mL
10nm, c
10ug/mL
10nm, c
10ug/mL
80nm, c
10ug/mL
80nm, c
10ug/mL
80nm, c
10ug/mL
80nm, c

9
50ug/mL
10nm, c
50ug/mL
10nm, c
50ug/mL
10nm, c
50ug/mL
10nm, c
50ug/mL
80nm, c
50ug/mL
80nm, c
50ug/mL
80nm, c
50ug/mL
80nm, c

10
11
100ug/mL 200ug/mL
10nm, c 10nm, c
100ug/mL 200ug/mL
10nm, c 10nm, c
100ug/mL 200ug/mL
10nm, c 10nm, c
100ug/mL 200ug/mL
10nm, c 10nm, c
100ug/mL 200ug/mL
80nm, c 80nm, c
100ug/mL 200ug/mL
80nm, c 80nm, c
100ug/mL 200ug/mL
80nm, c 80nm, c
100ug/mL 200ug/mL
80nm, c 80nm, c

Day 2: Addition of Dosing Solution
1. After 24 hours of incubation, aspirate media out of the plate.
2. Wash with 200 µL of PBS using multi-well pipette. Aspirate PBS.
3. Before adding the nanoparticles into solution, sonicate for 10 seconds.
4. Add 200 µL of dosing solutions or exposure media.
a. Dosing solutions in accordance with appropriate dilutions.
b. Exposure media is the control.
5. Incubate 24 hours in 37°C incubator.
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Table 6. Dosing solution calculations (1mL Solution)

For a 1 mL Solution:
Concentration
10µg/mL
50µg/mL
100µg/mL
200µg/mL

Exposure Media
(mL)
0.990
0.950
0.900
0.800

Ag NP (µL of a
1mg/mL solution)
10
50
100
200

Day 3: MTS
1. After 24-hour incubation, aspirate exposure media.
2. Wash cells with room temperature PBS 1-2 times to remove any
nanoparticles not in the cells.
3. Make a mixture of 20 µL MTS reagent plus 100 µL exposure media for
each well.
4. Add 120 µL of the mixture to each well using a multi-channel pipette.
5. Shake gently to mix well.
6. Incubate at 37°C for 1-4 hours (the reagent is yellow and will turn orangey
red to dark red depending on the amount of proliferation). It should be checked
every hour to determine when it needs to be read.
7. After incubation, put on shaker briefly to ensure that everything is evenly
mixed.
8. Read absorbance at 490 nm.
9. Transfer 80 µL of each well to a new plate and read absorbance at 490
nm. This is to ensure that there is no background due to nanoparticles.
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Appendix E: Lactate Dehydrogenase (LDH) Assay

LDH Materials: Promega CytoTox 96® Non-Radioactive Cytotoxicity Assay Kit
Exposure Media: F-12K Medium, Kaighn’s Modification of Ham’s F-12 with 1%
P/S, ATCC® (Manassas, VA)
Positive Control: Cadmium Oxide Nanoparticles
Day 1: Seeding the cells
1. Follow the procedure for cell culturing.
2. After counting the cells, make a solution that has 200,000 cells/mL in
growth media.
3. In a 96 well plate, add 200 µL to each well that is being used. Each
section should be marked with which type of nanoparticle and the dilution factor,
to include the positive Control, on the lid.
4. Incubate at 37°C for 24 hours.
Day 2: Addition of Dosing Solution
1. After 24 hours of incubation, aspirate media out of the plate.
2. Wash with 200 µL of PBS using multi-well pipette. Aspirate PBS.
3. Add 200 µL of dosing solutions or exposure media.
a. Dosing solutions in accordance with appropriate dilutions.
b. Exposure media is the control.
4. Add 200 µL of positive control solutions into appropriate wells.
5. Incubate 24 hours in 37°C incubator.
Day 3:
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1.

Remove 50 µL of media from the 96-well plate that has been incubating

and place into a new 96-well plate.
2.

Add 50 µL of exposure media to each well using a multi channel pipette.

3.

Add 50 µL of LDH assay buffer solution into each well. (add 12.0 mL

buffer solution to solute powder bottle – in kit)
4.

Incubate at room temperature for 30 minutes in the dark (can cover with

foil).
5. After 30 minutes add 50 µL of Stop Solution to each well.
6. Read absorbance at 490 nm immediately.

If combining with MTS Assay, also on day 3:
1. After completing the LDH portion of the testing, aspirate the media from
the original plate.
2. Wash the wells 3 times with 200 µL PBS using a multi-channel pipette.
3. Add 120 µL of exposure media and MTS solution to each well (100:20 µL
ratio).
4. Incubate at 37°C for 1-4 hours, watching for color change.
5. Read absorbance at 490 nm.
6. Remove 80 µL from each well and transfer to new plate.
absorbance at 490 nm.
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Read

Appendix F: Reactive Oxygen Species (ROS) Assay

DCHF-DA: 2’,7’– dichlorodihydrofluorescein diacetate, Invitrogen, Lot 478251,
100mg quantities
DMSO: Dimethyl Sulfoxide
Positive Control: 30% H2O2 dilutions
Growth/Exposure Media: Dulbecco’s Modified Eagle Medium/Nutrient (without
Phenol Red) Mixture, F-12 Ham solution was prepared in accordance with the
accompanying instructions. The growth media required the addition of 10% fetal
bovine serum (FBS) and 1% Penicillin/Streptomycin (P/S) Solution.

The

exposure media required a 1% Penicillin/Streptomycin (P/S) Solution addition.

1. Seed cells in 96-well black plate (approximately 150,000 cells/mL solution)
with 200 µL per well.
2. Incubate at 37°C for 48 hours.
3. Prepare reagents:
a. DCHF-DA (mw 487.3): 48 mg in 10 mL DMSO = 10 mM
i. Add 50 μL of stock solution into 5 mL growth media, to yield
a 100 μM DCFH-DA solution. For one 96-well plate, a 23
mL solution is needed.
b. Positive control (H2O2)
i. Add 114 μL of H2O2 into 10 mL of PBS to yield a 100 mM
Solution of H2O2.
ii. Prepare dosing concentration for positive control in exposure
media (500 μM – 2 mM).
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4. After incubation, aspirate media from wells and wash with 200 µL PBS for
each well.
5. Under dark conditions:
a. Add 200 µL of 100 µM DCFH-DA in growth media, incubate 20-30
minutes.
b. Aspirate media with DCFH-DA and wash with 200 µL PBS.
c. Add 200 µL of positive control or dosing solution and cover plates
with aluminum foil.
i. Make dosing solution with the required nanoparticle
concentrations; e.g. 10 µg/mL, 50 µg/mL, 100 µg/mL
ii. Positive control solution can have differing concentrations of
H2O2; e.g.10 mM solution, 1 mM solution, 0.1 mM solution,
0.01 mM solution.
d. Read background fluorescence values.
e. Place the plate in the incubator.
f. Measure fluorescence of the cells at excitation 485 nm and
emission at 530 nm at specified hour time points (e.g. 1, 4, 6, 24
hours).
g. Remove 80 µL of supernatant from each well and transfer to a new
96-well plate. Read fluorescence.
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